Mural Oncology PLC (NASDAQ:MURA) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| George Golumbeski Other companies: Acumen Pharmaceuticals, Inc. (Chairman of its Board of Directors · Since at least Nov 6, 2025); Shattuck Labs, Inc. (Director · Since at least Oct 8, 2020); Sage Therapeutics Inc (Director · Since at least Jan 22, 2019); Corbus Pharmaceuticals Holdings, Inc. (Director · Jul 6, 2020 – Jul 6, 2020 · Past); Enanta Pharmaceuticals, Inc. (Director · Feb 7, 2014 – Feb 26, 2020 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past) | Director · Since at least Jul 30, 2024 |
| Scott Thomas Jackson Other companies: Spero Therapeutics, Inc. (Director · Since at least Apr 16, 2020); MacroGenics, Inc. (Director · Since at least Jan 24, 2017); Crescent Biopharma, Inc. (Director · Nov 27, 2018 – May 1, 2024 · Past); Celator Pharmaceuticals Inc (Chief Executive Officer, Director · Jan 14, 2013 – Jul 12, 2016 · Past) | Director · Since at least Oct 31, 2023 |
| Benjamin Hickey Other companies: Bristol-Myers Squibb Company (President, RayzeBio Org. · Since at least Feb 26, 2024); Surface Oncology Inc (Director · Dec 9, 2021 – Jun 8, 2022 · Past); Halozyme Therapeutics, Inc. (SVP, Chief Commerical Officer · Sep 10, 2018 – Oct 1, 2019 · Past) | Director · Since at least Oct 31, 2023 |
| Susan Altschuller Other companies: Climb Bio, Inc. (Chief Financial Officer · Since at least Oct 1, 2025); Cerevel Therapeutics Holdings Inc (Chief Financial Officer · May 15, 2023 – Aug 1, 2024 · Past); ImmunoGen Inc (SVP AND CFO · Jul 20, 2020 – May 20, 2022 · Past) | Director · Oct 31, 2023 – Aug 14, 2024 · Past |
| Adam D Cutler Other companies: InMed Pharmaceuticals Inc. (Director · Nov 12, 2020 – Jan 24, 2022 · Past); Molecular Templates Inc (See remarks · Nov 13, 2017 – Feb 15, 2021 · Past) | Chief Financial Officer · Since at least Nov 15, 2023 |
| Francis M Cuss Other companies: Rubius Therapeutics Inc (Director · Jul 17, 2018 – May 12, 2022 · Past); Bristol-Myers Squibb Company (EVP & CSO · May 4, 2010 – Mar 10, 2017 · Past) | Director · Since at least Oct 31, 2023 |
| Maiken Keson-Brookes Other companies: Rubius Therapeutics Inc (CLO & Corp. Secretary · Nov 18, 2019 – Jan 29, 2022 · Past); uniQure N.V. (General Counsel · Jan 1, 2017 – Jan 27, 2017 · Past) | Chief Legal Officer · Since at least Nov 15, 2023 |
| Sachiyo Minegishi Other companies: Akouos Inc (Chief Financial Officer · Oct 1, 2020 – Dec 1, 2022 · Past) | Director · Since at least Sep 20, 2024 |
| Vicki L Goodman Other companies: Exelixis, Inc. (EVP, Prod Dev & Med Aff &CMO · Jan 4, 2022 – Apr 3, 2023 · Past) | Chief Medical Officer · Since at least Nov 15, 2023 |
| Caroline Loew | Chief Executive Officer, Director · Since at least Oct 31, 2023 |